VLN Form 144: Insider sales listed, 16,250 shares proposed

VLN reported a Form 144 notice for proposed sales of ordinary shares by a holder and disclosed recent completed sales.

Accepted by SEC EDGAR 02/23/2026 - 08:45 AM EST Learn about SEC filing dates

Rhea-AI Filing Summary

VLN reported a Form 144 notice for proposed sales of ordinary shares by a holder and disclosed recent completed sales. The notice lists 16,250 shares to be sold under an Employee Stock Option Plan, and records three sales by Dror Jerushalmi: 12/05/2025 for 42,631 shares ($72,760.69), 01/02/2026 for 254,131 shares ($463,648.70), and 02/02/2026 for 150,758 shares ($233,264.22).

Insights

Securities Compliance Counsel

Form 144 documents proposed and recent sales of ordinary shares by an insider or holder.

The filing lists 16,250 shares proposed for sale under an Employee Stock Option Plan and records three completed sales by Dror Jerushalmi on 12/05/2025, 01/02/2026, and 02/02/2026 with proceeds shown in the excerpt.

This notice is procedural: subsequent consummation of the proposed sale depends on market execution and compliance with Rule 144 timing and volume limitations; timing and additional conditions are not detailed in the excerpt.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does VLN's Form 144 disclose about proposed sales?

The Form 144 lists a proposed sale of 16,250 ordinary shares under an Employee Stock Option Plan. The filing identifies the planned sale method as cash upon exercise and names Oppenheimer & Co. as broker details in the excerpt.

Who completed recent share sales reported in VLN's filing?

The filing records three completed sales by Dror Jerushalmi: 12/05/2025 (42,631 shares, $72,760.69), 01/02/2026 (254,131 shares, $463,648.70), and 02/02/2026 (150,758 shares, $233,264.22).

Does the Form 144 show who will receive proceeds from the proposed sale?

The excerpt indicates the securities to be sold are tied to an Employee Stock Option Plan and lists cash upon exercise as the method. The filing does not state any alternate recipient; proceeds treatment beyond that phrase is not detailed in the excerpt.

Which broker is named in the VLN Form 144 excerpt?

The excerpt names Oppenheimer & Co. Inc. with an address at 85 Broad St., New York, NY. The broker listing appears in the securities section associated with the proposed sale entries in the excerpt.

Are the numbers in the filing final sales or proposed amounts?

The three dated entries for Dror Jerushalmi are recorded as sales during the past three months with share counts and proceeds, which appear as completed transactions. The 16,250 figure is shown as securities to be sold, a proposed amount under the plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001965405
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Valens Semiconductor Ltd.
SEC File Number	001-40842
Address of Issuer	8 HANAGAR ST. POB 7152 HOD HASHARON, 4501309 ISRAEL 00000
Phone	972-9-762-6900
Name of Person for Whose Account the Securities are To Be Sold	Jerushalmi Dror
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary	Oppenheimer & Co. Inc. 85 broad st. New York NY 10004	16250	24212.50	106342415	02/20/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary	01/11/2019	Employee Stock Option Plan	Issuer			16250	02/20/2026	Cash - Upon Exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Dror Jerushalmi 8 HANAGAR ST. POB 7152 HOD HASHARON L3 4501309	Ordinary	12/05/2025	42631	72760.69
Dror Jerushalmi 8 HANAGAR ST. POB 7152 HOD HASHARON L3 4501309	Ordinary	01/02/2026	254131	463648.70
Dror Jerushalmi 8 HANAGAR ST. POB 7152 HOD HASHARON L3 4501309	Ordinary	02/02/2026	150758	233264.22

144: Remarks and Signature

Remarks
Date of Notice	02/20/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Dror Jerushalmi
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)